Continuing Medical Education news from FierceHealthcare
News
Reform bill would require pharma disclosures of CME funding
While it's gotten relatively little attention from pundits, provisions within reform bills passing through Congress would demand that pharmaceutical companies disclose how they're spending on... Read more...
Glaxo stops funding commercial CME; Merck funding $150M non-profit vaccine developer;
> In another sign that drugmakers want to reduce their exposure to payola allegations, GlaxoSmithKline has announced that it will stop funding commercial continuing medical education programs.... Read more...
SPOTLIGHT: AMA conflict of interest policy still in the works, a year later
Some might say a year of debate is long enough, even for Congress. But at the American Medical Association, they're taking their time over a new ethics policy designed to limit pharmaceutical company... Read more...
Struggle over conflict-of-interest rules at U of Minnesota
A struggle is currently under way over revisions to conflict-of-interest rules at the University of Minnesota Medical School, one that offers a glimpse into the complexity of making real changes in... Read more...
Harvard Med School strengthens conflict-of-interest rules
Harvard Medical School has set plans to strengthen conflict-of-interest rules for its doctors and researchers, amid criticism over its existing rules and a U.S. Senate investigation of several of its... Read more...
Study: Doctors largely support commercial funding for CME
The healthcare industry may be in an uproar over pharma and medical devicemaker funding for physician activities, but physicians don't seem to be so conflicted, if a recent study is to be believed.... Read more...
Medtronic to disclose gifts to healthcare groups
Perhaps going with the prevailing winds--which definitely favor disclosing gifts to healthcare players before the state makes you do it--medical devicemaker Medtronic has decided to voluntarily... Read more...
Stanford limiting drugmaker CME financing
Today, Stanford University is expected to announce that it will set strict limits on pharmaceutical industry financing of continuing education for doctors at its medical school. This marks a major... Read more...
